Plaintiff says if hearing had been tested before and after Tepezza infusions, she may have stopped using the drug in time to prevent permanent hearing loss
Tepezza hearing damage lawsuits claim the manufacturer failed to warn patients and the medical community that the thyroid eye disease drug could cause hearing loss and tinnitus.
The attorneys will take actions which will benefit all plaintiffs pursuing a Tepezza lawsuit over hearing loss and tinnitus.
The U.S. JPML rejected Horizon's arguments that the litigation would not beneft from Tepezza lawsuits over hearing loss being consolidated before one judge
Neither the plaintiff nor her doctors were warned that Tepezza could cause irreversible hearing loss, lawsuit claims
Acquiring Tepezza and Krystexxa would give Amgen a monopoly on those treatments, which it could then use to smother competition, the FTC warns
Lawsuits continue to be filed against Horizon Therapeutics over their failure to warn patients and doctors about the long term hearing loss side effects from Tepezza.
Plaintiffs say identical facts, injuries and legal arguments make the Tepezza infusion lawsuits ripe for consolidation as part of a multidistrict litigation.
The Tepezza lawsuit claims the manufacturer knew about the risk of hearing loss side effects, but failed to warn patients and the medical community
At least 18 Tepezza lawsuits over hearing loss are pending in multiple federal courts nationwide, and the number of claims is expected to continue to grow
